fundraising >
Loading...
Loading investors...
16,371 investors
16,371 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Open Ocean Capital VC firm | N/A | N/A | N/A |
|
| |||||
![]() | Apis & Heritage Ca... Other | N/A | N/A | N/A |
|
Send email
| |||||
![]() | Red Cedar Ventures VC firm | N/A | N/A | 2. Prototype 3. Early Revenue |
|
Send email
| |||||
![]() | Aquilo Capital Man... VC firm | USA | N/A | 3. Early Revenue |
|
| |||||
![]() | RSF Social Finance VC firm | N/A | N/A | N/A |
|
Send email
| |||||
![]() | ArchiMed Other | France | N/A | N/A | We invest in biopharma, medtech, life sciences, healthcare IT, public safety, consumer health, care providers, diagnostics. See below for details.
Biopharma: Including small and large molecules, APIs, Generic, Primary and Specialty Pharma, Pharma delivery, Veterinary (animal health); Outsourcing Services such as bioanalytical, drug discovery or formulation services, CRO, CDMO, CLO or specialized consulting etc.
Medtech: Including implants, equipment, consumables, services, outsourcing in field such as Cardiovascular, Dental, Drug Delivery, Infection control, Neuro, Ophtalmo, Orthopaedics, General surgery, Wound Care, Veterinary, etc.
Life Sciences: Including tools, equipment, consumables and services, whether for Bioprocessing (upstream, downstream, final fill) and Research, etc.
Healthcare IT: Clinical or Non-Clinical solutions for Care Providers, Care Payer solutions, Biopharma-related Software, Outsourcing services, etc.
Public Safety: Biocontrol, Food safety, Environmental and Healthcare-related TIC (testing, inspection, certification), Health at work, etc.
Consumer Health: Cosmetics, Health supplements, Aesthetics, Wellness, Selfcare, Physio, etc.
Care Providers: Homecare, Specialized care delivery, Outsourcing services, etc.
Diagnostics: Including In Vitro (IVD) and Imaging, etc. |
|
| ||||
![]() | Saudi Aramco Entre... | Saudi Arabia | N/A | N/A |
|
| |||||
![]() | Abdulaziz Binzaraa...
Solo angel | Canada USA China Hong Kong India Indonesia Japan Malaysia Philippines Singapore South Korea Sri Lanka Taiwan | $5k to $100k | 2. Prototype 3. Early Revenue4. Scaling | I invest in tech | Advice
|
|
| |||
![]() | CT Equity Group, L... | USA | N/A | 4. Scaling |
|
| |||||
![]() | Cream City Venture... | N/A | N/A | 2. Prototype 3. Early Revenue |
|
| |||||
![]() | Azure Capital Part... VC firm | USA Canada | N/A | 3. Early Revenue |
|
Send email
| |||||
![]() | SGIF Sports Gaming... VC firm | N/A | N/A | 2. Prototype 3. Early Revenue |
|
| |||||
![]() | Socialatom Venture... VC firm | USA | N/A | N/A |
|
Send email
| |||||
![]() | Kenneth Book
Solo angel | USA | $1k to $25k | 1. Idea or Patent 2. Prototype3. Early Revenue4. Scaling | I invest in companies solving hard and important problems. I have a bias toward fintech, marketplaces and biotech. | Will be the easiest investor on your cap table: always there when you want a sounding board or help, but will stay out of your way if that's what you prefer. Happy to help with fundraising, partnerships, etc as needed.
|
|
| |||
![]() | Great Lakes Angels... | N/A | N/A | N/A |
|
Send email
| |||||
![]() | Anglo Scientific VC firm | UK | N/A | 3. Early Revenue |
|
Send email
| |||||
![]() | Viss Media VC firm | N/A | N/A | 4. Scaling 5. Growth |
|
| |||||
![]() | Reginald Chatman
Solo angel | USA | $1k to $5k | 3. Early Revenue | I invest in B2B SaaS with ARR>$12,000 | Customer Relationship Management
|
|
| |||
![]() | Sterling Commercia... | USA | N/A | N/A |
|
Send email
| |||||
![]() | Bruce Bower
Solo angel | UK | $10k to $100k | 3. Early Revenue 4. Scaling | I invest in B2B software/services and healthcare .
Need to see the following:
- strong founder(s)
- generating meaningful revenue
- <10 mln valuation
- <2 mln round size | I write checks and get out of your way
Know something about health care in Europe; and raising debt and venture funding
|
|
| |||




USA

France
Saudi Arabia
Canada
China
Hong Kong
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Sri Lanka
Taiwan







UK


